Analyst Recommendations
1,023.72 -20.94(-2.00%)07/03/2024
Regeneron Pharmaceuticals, Inc. (REGN)
Regeneron Pharmaceuticals, Inc. (REGN)
2024: Total Recommendations Consensus
To Grade | # of Recommendations |
---|---|
Outperform | 9 |
Buy | 6 |
Neutral | 5 |
Overweight | 3 |
Underperform | 1 |
5 records were shown. To view all data, Upgrade to PRO plan with only $1
Upgrades & Downgrades